Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings

British Journal of Nutrition

Volumn 108, Issue 3, 2012, Pages 431-439

  Elgass, Simone ^a   Cooper, Alan ^a   Chopra, Mridula ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Angiogenesis; Human umbilical vein endothelial cells; Lycopene; Rat aortic rings; TNF; Vascular endothelial growth factor

Indexed keywords

LYCOPENE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUTRIENT CONCENTRATION; NUTRITIONAL VALUE; RAT; VASCULAR RING;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTICARCINOGENIC AGENTS; AORTA; CAROTENOIDS; CELL PROLIFERATION; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865219359     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005800     Document Type: Article

References (53)

1. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650-1659. (Pubitemid 17052899)
2. Nagy JA, Brown LF, Senger DR, et al. (1989) Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948, 305-326. (Pubitemid 19055388)
3. Ziegler RG (1989) A review of epidemiological evidence that carotenoids reduce the risk of cancer. J Nutr 119, 116-122. (Pubitemid 19059544)
4. Giovanucci E (1999) Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Nat Cancer Inst 91, 317-331.
5. Rao AV & Agarwal S (2000) Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 19, 563-569.
6. Levy J, Bosin E, Feldman, et al. (1995) Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or b-carotene. Nutr Cancer 24, 257-266.
7. Rehman A, Bourne LC, Halliwell, et al. (1999) Tomato consumption modulates oxidative DNA damage in humans. Biochem Biophys Res Commun 262, 828-831. (Pubitemid 29443743)
8. Karas M, Amir H, Fishman D, et al. (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36, 101-111. (Pubitemid 30317841)
9. Hwang ES & Lee HJ (2006) Inhibitory effects of lycopene on the adhesion, invasion and migration of SK-Hep1 human hepatoma cells. Exp Biol Med (Maywood) 231, 322-327.
10. Pennathur S, Maitra D, Byun J, et al. (2010) Potent antioxidant activity of lycopene: a potential role in scavenging hypochlorus acid. Free Rad Biol Med 49, 205-213.
11. Yang H-M, Yen Y-T, Uang C-S, et al. (2011) Growth inhibitory efficacy of lycopene and b-carotene against androgenindependent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res 55, 606-612.
12. Bhat TA & Singh RP (2008) Tumor angiogenesis - a potential target in chemoprevention. Food Chem Toxicol 46, 1334-1345. (Pubitemid 351258200)
13. Auerbach R, Lewis R, Shinners B, et al. (2003) Angiogenesis assays: a critical review. Clin Chem 49, 32-40.
14. Lee A, Thurnham DI & Chopra M (2000) Consumption of tomato products with olive oil but not sunflower oil increases the antioxidant activity of plasma. Free Rad Biol Med 29, 1051-1055.
15. Porrini M & Riso P (2005) What are typical lycopene intakes? J Nutr 135, 2042S-2045S. (Pubitemid 41099772)
16. Maiani G, Caston MJP, Catasta G, et al. (2009) Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res 53, S194-S218.
17. Olmedilla B, Granado F, Southon S, et al. (2002) A European multicentre, placebo controlled supplementation study with a-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Clin Sci 102, 447-456. (Pubitemid 34275797)
18. Porrini M, Riso P & Testolin G (1998) Absorption of lycopene from single or daily portions of raw and processed tomatoes. Br J Nutr 80, 353-361. (Pubitemid 28515362)
19. Richelle M, Bortlik K, Liardt S, et al. (2002) A foodbased formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr 132, 404-408. (Pubitemid 34208741)
20. Porrini M, Riso P, Brusamolino A, et al. (2005) Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves antioxidant protection. Br J Nutr 93, 93-99.
21. Kim JY, Paik JK, Kim OY, et al. (2011) Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 215, 189-195.
22. Bowen P, Chen L, Stacewicz-Sapuntzakis M, et al. (2002) Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med 227, 886-893. (Pubitemid 35340343)
23. Chopra M, O'Neill ME, Keogh N, et al. (2000) Influence of increased fruit and vegetable intake on plasma and lipoprotein carotenoids and LDL oxidation in smokers and nonsmokers. Clin Chem 46, 1818-1829.
24. Gartner C, Stahl W & Sies H (1997) Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 66, 116-122. (Pubitemid 27278908)
25. Stahl W & Sies H (1992) Uptake of lycopene and its isomer is greater from heat-processed then from unprocessed tomato juice. J Nutr 122, 2161-2166.
26. Graziani G, Pernice R, Lanzuise S, et al. (2003) Effect of peeling and heating on carotenoid content and antioxidant activity of tomato and tomato-virgin olive oil systems. Eur Food Res Techol 216, 116-121. (Pubitemid 38350137)
27. O'Neill MEO, Carroll Y, Corridan B, et al. (2001) A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr 85, 499-507. (Pubitemid 32435544)
28. Etminan M, Takkuche B & Cammano-Isoma F (2004) The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 13, 34-35.
29. Gann PH, Ma J, Giovannucci E, et al. (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59, 1225-1230. (Pubitemid 29136251)
30. Paetau, Khachik F, Brown ED, et al. (1998) Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am J Clin Nutr 68, 1187-1195. (Pubitemid 28550947)
31. van Eenwyk J, Davis FG & Bowen PE (1991) Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 48, 34-38.
32. Batieha AM, Armenian HK, Norkus EP, et al. (1993) Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 2, 335-339.
33. Lu Q-Y, Hung J-C, Heber D, et al. (2001) Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev 10, 749-756. (Pubitemid 32695154)
34. Szmourlo A, Marcozak M, Rudnicka L, et al. (1991) Beta-carotene in prevention of cutaneous carcinogenesis. Acta Derm Venereol 71, 528-530.
35. Dembinska-Kiec A, Polus A, Kiec-Wilk B, et al. (2005) Proangiogenic activity of beta-carotene is coupled with activation of endothelial cell chemotaxis. Biochim Biophys Acta 1740, 222-239. (Pubitemid 40798233)
36. Guruvayoorappan C & Kuttan G (2007) Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integr Cancer Ther 6, 258-270. (Pubitemid 47301119)
37. Huang CS, Liao JW & Hu ML (2008) Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J Nutr 138, 538-543.
38. Sahin M, Sahin E & Gumuslu S (2011) Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation. Acta Histochem, (Epublication ahead of print version 5 April 2011).
39. Fuhrmann-Benzakein E, Ma AN, Rubbia-Brandt L, et al. (2000) Elevated levels of angiogenic cytokines in the plasma of cancer patients. Int J Cancer 85, 40-45.
40. Minuzzo S, Moserle L, Indraccolo S, et al. (2007) Angiogenesis meets immunology: cytokine gene therapy of cancer. Mol Aspects Med 28, 59-86.
41. Sainson RCA, Johnston DA, Chu HC, et al. (2008) TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 111, 4997-5007.
42. Malaguarnera L, Imbesi R, Di Rosa M, et al. (2005) Action of prolactin, IFN-g, TNF-a and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. Int Immunopharmacol 5, 1458-1469. (Pubitemid 40813302)
43. Nakashima J, Tachibana M, Ueno M, et al. (1998) Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin Cancer Res 4, 1743-1748. (Pubitemid 28304737)
44. Michalaki V, Syrigos K, Charles P, et al. (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90, 2312-2316. (Pubitemid 38961893)
45. Giovannucci E (2002) A review of epidemiologic studies of tomatoes, lycopene and prostate cancer. Exp Biol Med (Maywood) 227, 852-859. (Pubitemid 35340338)
46. Rao AV, Fleshner N & Agarwal S (1999) Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case control study. Nutr Cancer 33, 159-164. (Pubitemid 29270003)
47. Erhardt JG, Meisner C, Bode JC, et al. (2003) Lycopene, b-carotene and colorectal adenomas. Am J Clin Nutr 78, 1219-1224.
48. Teicher BA (1995) Angiogenesis and cancer metastases: therapeutic approaches. Crit Rev Oncol Hematol 20, 9-39.
49. Hantz HL, Young LF & Martin KR (2005) Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cells. Exp Biol Med (Maywood) 135, 2119-2123.
50. Salman H, Bergman M, Djaldetti M, et al. (2007) Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed Pharmacother 61, 366-369. (Pubitemid 47193174)
51. Palozza P, Simone RE, Catalano A, et al. (2011) Tomato lycopene and lung cancer prevention: from experimental to human studies. Cancers 3, 2333-2357.
52. Cavallaro U & Christofori G (2000) Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol 50, 63-70. (Pubitemid 32166291)
53. Heidenreich A, Aus G, Bolla M, et al. (2008) EAU guidelines on prostate cancer. Eur Urol 53, 68-80 (Pubitemid 350166735)